Pegfilgrastim – Rational Drug Design for the Management of Chemotherapy-Induced Neutropenia

Publisher： Karger

E-ISSN： 2296-5262|28|11|595-602

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.11, 2005-10, pp. : 595-602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegfilgrastim Prophylaxis for Cladribine-Induced Neutropenia in Patients with Hairy-Cell Leukemia

By  

Acta Haematologica, Vol. 132, Iss. 1, 2014-02 ,pp. : 118-121

Karger

Access to resources Recommend Favorite

Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study

By Fiegl Michael   Steger Günther G.   Studnicka Michael   Eisterer Wolfgang   Jaeger Christine   Willenbacher Wolfgang  

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 505-515

Informa Healthcare

Access to resources Recommend Favorite

NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis

By  

Oncology Research and Treatment, Vol. 38, Iss. 5, 2015-05 ,pp. : 221-229

Karger

Access to resources Recommend Favorite

Comparison of Low-Dose versus Standard-Dose Colony Stimulating Factor in Patients with Chemotherapy-Induced Febrile Neutropenia

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 283-284

Karger

Access to resources Recommend Favorite

Prevention and Treatment of Chemotherapy-Induced Neutropenia with the Biosimilar Filgrastim: A Non-Interventional Observational Study of Clinical Practice Patterns

By  

Oncology Research and Treatment, Vol. 38, Iss. 4, 2015-03 ,pp. : 146-152

Karger

Access to resources Recommend Favorite